TRPA1 antagonists (Genomics Institute of the Novartis Research Foundation/Alcon/Scripps Research Institute)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTRPA1 antagonists (Genomics Institute of the Novartis Research Foundation/Alcon/Scripps Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTransient receptor potential cation channel subfamily A member 1 inhibitors
TargetsTransient receptor potential cation channel subfamily A member 1
Therapy Area/IndicationsEye Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenomics Institute of the Novartis Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenomics Institute of the Novartis Research FoundationThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsEye Pain

Other Information

ATC CodeN/A
Related LinksN/A